Aurinia Pharmaceuticals Inc (AUPH)

EBITDA Growth

93.94%

Quarterly · Period ending:

AUPH logo

AUPH EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported93.94%
AUPH Quarterly EBITDA YoY % (-471.77% → 93.94%)
High-resolution chart · PNG

AUPH ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
93.9368%
64.3532%
555.4519%
76.1383%
274.212%
880.2062%
135.6253%
422.3062%
166.2467%
84.5128%
19.2816%
10.227%
67.259%
31.8879%
21.7375%
85.3964%
24.8743%
26.6224%
-233.8355%
-17.8933%
-74.9867%
-101.7508%
87.422%
-125.4808%
-70.2389%
-106.6883%
-431.1015%
-3.7917%
-1.2154%
20.2799%
-16.3441%
-33.5567%
-58.1155%
-47.7899%
-60.5483%
-167.0644%
-131.1679%
-128.7668%
10.3779%
16.1161%
26.4018%
13.8664%
-89.5542%
-58.6974%
-36.1982%
-54.8445%
-471.2128%
-25.2321%
-392.5708%
-392.489%
84.1524%
-104.724%
50.0868%
-183.4498%
-305.2045%
-67.9937%
-133.1291%
84.5508%
207.7942%
24.3253%
2,534.9995%
-124.2037%
-62.7679%
27.3109%
90.7866%
72.1891%
-53.993%
53.8895%
56.2028%
48.6437%
89.5099%
55.5486%
44.4751%
27.7377%
-47.4712%
-25.467%
-61.8227%
-48.3431%
34.8345%
4.0753%
11.7252%
34.8868%
-11.7995%
-4.1522%
-99.7826%
-129.2407%
-66.242%
-62.3782%
-258.9557%
-1.318%
-71.7397%
-306.3471%
-16.1892%
-31.6299%
180.139%
177.6868%
-1.4739%
-61.9946%
-90.7353%
-194.9806%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.